Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Oncotarget|April 28, 2017
Inhibition of mTORC2 component RICTOR impairs tumor growth in pancreatic cancer modelsKatharina M Schmidt, Claus Hellerbrand, Petra Ruemmele, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 18, 2014
IL-13 orchestrates resolution of chronic intestinal inflammation via phosphorylation of glycogen synthase kinase-3βStefan Fichtner-Feigl, Rebecca Kesselring, Maria Martin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 2, 2008
Expression of CD24, P-cadherin and S100A4 in tumors of the ampulla of VaterDaniel Baumhoer, Marc-Oliver Riener, Inti Zlobec, et al.
Journal of Hepatology|January 17, 2013
Bile duct damage after cold storage of deceased donor livers predicts biliary complications after liver transplantationStefan M Brunner, Henrik Junger, Petra Ruemmele, et al.
The Journal of Clinical Investigation|April 27, 2011
Tumor development in murine ulcerative colitis depends on MyD88 signaling of colonic F4/80+CD11b(high)Gr1(low) macrophagesGabriela Schiechl, Bernhard Bauer, Ivan Fuss, et al.
Cancer Letters|November 26, 2008
Silencing of MGMT expression by promoter hypermethylation in the metaplasia-dysplasia-carcinoma sequence of Barrett's esophagusDoerthe Kuester, Wa'el El-Rifai, DunFa Peng, et al.
Neoplasia (New York, N.Y.)|October 26, 2012
STAT5b as molecular target in pancreatic cancer--inhibition of tumor growth, angiogenesis, and metastasesChristian Moser, Petra Ruemmele, Sebastian Gehmert, et al.
Pathology, Research and Practice|July 16, 2010
Aberrant methylation of DAPK in long-standing ulcerative colitis and ulcerative colitis-associated carcinomaDoerthe Kuester, Thomas Guenther, Susanne Biesold, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
Loss of p16 protein defines high-risk patients with gastrointestinal stromal tumors: a tissue microarray studyRegine Schneider-Stock, Carsten Boltze, Jerzy Lasota, et al.
Genetic Testing|June 10, 2005
Deletions account for 17% of pathogenic germline alterations in MLH1 and MSH2 in hereditary nonpolyposis colorectal cancer (HNPCC) familiesMonika Grabowski, Yvonne Mueller-Koch, Eva Grasbon-Frodl, et al.
Pageof 5